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ABSTRACT
MER-25, which acts as an antiestrogen on most estrogen-
sensitive behaviors and in peripheral tissues, acts only as
an estrogen with respect to eating and body weight. MER-25
fails to antagonize the effects of EB on eating and body
weight, while simultaneously antagonizing EB's effects on
female sexual behavior, uterine growth, and vaginal cytology.
Estradiol benzoate (EB) and MER-25 similarly affect eating
and body weight in gonadectomized rats and gerbils. In rats,
both compounds cause a transient decrease in food intake and
a permanent decrease in body weight relative to controls;
the eating and body weight effects of both MER-25 and EB
are attenuated by progesterone; both MER-25 and EB affect
females more than males; MER-25 decreased food intake when
implanted in the same hypothalamic areas in which EB decreases
food intake; and both EB and MER-25 reduce body weight by
means independent of food intake reductions. In gerbils,
both EB and MER-25 increase food intake and body weight.
The decrease in eating and weight gain caused by MER-25 are
not due to toxicity, as indicated by its failure to induce
a learned aversion to saccharin and its failure to alter
running wheel activity. These results indicate that the
systems mediating the effects of estrogens on eating and body
weight differ biochemically from other behavioral and somatic
estrogen-sensitive systems.
In studies directed at the inhibitory behavioral actions
of antiestrogens, the hypothesis that antiestrogens compete
with estradiol for binding sites in the brain was tested.
Effects of antiestrogens on estradiol binding were compared
with their effects on female sexual behavior. The non-
steroidal antiestrogens, MER-25, CI628, and nafoxidine reduce
the uptake of H-estradiol in whole homogenates and isolated
cell nuclei of brain tissues and in similar paradigms block
the induction of female sexual behavior. The antiestrogens
were injected intraperitoneally 2 hours prior to an intra-
3
venous injection of H-estradiol, and the animals were killed
2 hours after the estradiol injection. Cl-628 reduces radio-
activity in whole homogenates and purified cell nuclei of
cerebral cortex, hypothalamus, preoptic area-septum, as well
as the pituitary. Nafoxidine reduces uptake in cell nuclei
of the hypothalamus, preoptic area-septum, and pituitary.
In this paradigm, MER-25 inhibits uptake in the pituitary,
but not in the brain. In the analogous behavioral experiments,
with antiestrogens injected 2 hours prior to an intravenous
injection of unesterified estradiol, CI-628 and nafoxidine
totally inhibit lordosis responding. MER-25 shows no inhi-
bition of behavior in this paradigm. However, when MER-25
is injected 12 hours prior to the estradiol, it inhibits
.
3
retention of H-estradiol at 2 hours in brain and pituitary
cell nuclei, and lordosis responding is also inhibited.
Additionally, the antiestrogens can apparently displace
3
previously bound H-estradiol. When the antiestrogens are
3
injected 2 hours prior to an injection of H-estradiol,
vi
MER-25, CI-628, and nafoxidine all show greater inhibition
of nuclear estradiol retention at 12 hours after the V
estradiol injection than at 2 hours. Analagously, when CI-
628 is injected 2 hours after an intravenous injection of
H-estradiol, it displaces most of the radioactivity present
in hypothalamic-preoptic area nuclei at 12 hours after the
estradiol injection. These results indicate that anti-
estrogens can prevent or reverse the nuclear concentration
of estradiol in brain cells and are consistent with a role
of the cell nucleus in the induction of estrous behavior by
estradiol.
vii
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INTRODUCTION
Estradiol affects both eating and female sexual
behavior in rats by actions in the central nervous system.
Small implants of estradiol in the hypothalamus cause a
decrease in food intake and induce sexual receptivity
(Beatty et al., 197i+; Dorner et al., 1968; Jankowiak and
Stem, 197k; Lisk, 1962; Wade and Zucker, 1970), while
implants in other regions of the brain do not. Lesions of
parts of the hypothalamus reduce the sensitivity of rats
to the effects of systemic estradiol injections on food
intake (Beatty et al., 1975). Likewise, lesions of the
diencephalon either enhance or diminish the estrogen-
responsiveness of the lordosis reflex, depending on the
location of the damage (Law and Meagher, 1958; Powers and
Valenstein, 1972; Singer, I968).
Antiestrogens may be useful in analyzing the behavioral
actions of estradiol. These synthetic compounds inhibit
the actions of estrogens on a variety of measures. The
antiestrogen MER-25 has been studied extensively in a variety
of species and has been found to antagonize the effects of
estrogens on the uterus, vagina, mammary gland, eviduct,
and brain (e.g., Giannina et al., 1971+; Komisaruk and Beyer,
1972; Lerner, I96I4.; Lerner et al., 1958; McDonald, 1973;
Meyerson and Lindstrom, I968; Sodersten, 1971;; Stone and
Emmens, 1961;; Roy and Wade, 1975). For example, estradiol-
induced uterine weight increases can be attenuated and
vaginal cornification prevented by MER-25 administration.
Female sexual behavior and estradiol- induced increases in
locomotor activity can be inhibited by anties trogens
, as
well as estradiol-induced alterations in gonadotropin
release (Arai and Gorski, 1968; Labhsetwar, 1970; Roy and
Wade, 1975)- The compounds do not inhibit or mimic
androgens or progestins (Lerner et al., 1958).
PART I
EFFECTS OF AN ANTIESTROGEN ON POOD INTAKE
AND BODYWEIGHT
There has been no published study designed to determine
whether anties trogens will inhibit estradiol's actions on
eating and body weight regulation. In fact, available
data suggest that the antiestrogen MER-25 might itself
produce the same effects as estradiol (Beyer and Vidal,
1971; Lerner et al., 1958; Lerner et al., 1966).
In most mammalian species estradiol decreases eating
and body weight in intact females and ovariectomized
animals given the hormone exogenously. The effects have
been most clearly characterized in rats (see Wade 1976 for
review): 1) The effects on food intake of either ovariectomy
(OVX) or continued replacement injections of estradiol
benzoate are transient, while the body weight changes are
permanent (Gentry and Wade, 1976a; Mook et al., 1972;
Tarttelin and Gorski, 1971; Wade, 1975). 2) Progesterone
antagonizes the action of estradiol on f.i. and BW, but
has no effects of its own (Wade, 1975; Ross and Zucker,
I97I4.). 3) Females are more sensitive than males to the
affect of EB injections on food intake (Gentry and Wade,
1976b), I|) Estradiol will produce a reduction of food
intake when implanted in the ventromedial hypothalamus
(Beatty et al., 197i|; Jankowiak and Stem, 1971;; Wade and
Zucker, 1970). 5) Some actions of EB on body weight reduc-
;e3
tion are apparently independent of food intake change
(Blaustein et al., 1976, ; Dubuc, 1976). In female
Mongolian gerbils, estradiol produces effects on eating and
body weight opposite to those produced in rats; injections
of EB increase food intake and body weight (Maass and Wade,
unpublished).
The first experiment assesses the ability of the anti-
'
estrogen MER-25 to inhibit the effects of EB on food intake
and body weight. The subsequent studies determine to what
extent the effects on eating and body weight of an anti-
estrogen, MER-25, parallel those of EB.
General Method
The subjects were Sprague-Dawley rats obtained from
Charles River Breeding Laboratories (Wilmington, Mass.)
and Mongolian gerbils obtained from Tumblebook Farms,
(Northfield, Mass.). Animals were castrated at various times
before treatment as indicated in each experiment. Gonad-
ectomies were performed through a single ventral incision
under sodium pentobarbital (Nembutal, i;0 mg/kg) or methoxy-
flurane (metofane) anesthesia. Animals were housed indivi-
dually, and the lighting cycle provided 12 hours of light
and dark. Injections were given daily 1-2 hours prior to
the onset of dark. Substances to be injected were dissolved
or suspended in sesame oil to a final volume of 0.1 cc
(except the 20 mg dose of MER-25 which was in 0.2 cc oil)
and injected subcutaneously. Purina Laboratory Chow pellets
were available ad libitum except where otherwise noted.
Pood intake was measured daily in the rat studies and twice
£ week in the gerbil study to the nearest 0.1 g during
the middle of the light period with spillage collected.
Body weight was measured to the nearest 1 g every third day.
Data were analyzed by the appropriate
_t test for between-
group or within-group comparisons or by analysis of variance
EXPERIMENT 1. COMPARISON OF THE EFFECTS OF MER-25
ON THE ACTIONS OF ESTRADIOL ON FOOD INTAKE, FEMALE
SEXUAL BEHAVIOR, UTERINE WEIGHT, AND VAGINAL CYTO-
LOGY
This experiment tested whether MER-25 would antagonize
EE's effects on eating and body weight. Two doses were
tested and concurrent comparisons made with the effects on
sexual behavior, vaginal cytology, and uterine weight.
Procedure
Part 1. Fourteen females averaging 250 g were ovari-
ectomized; the following day injections were begun. Group
1 (n=5) received the oil vehicle; Group 2 (n=5) received
2 ug/day of EB; Group 3 (n=i; received 2 ug of EB and 5 mg
of MER-25. Pood intake was measured daily and body weight
every third day. Sexual behavior was tested under red
illumination during the dark phase with male rats on the
i\.th and 9th days of injection. Injections were continued
for 22 days, and then the animals were sacrificed and
uterine weights measured.
Part 2. Thirty females were ovariectomized 3l|- days
prior to treatment. Animals were assigned to one of four
groups, balanced according to baseline food intake and
body weight. The animals received daily injections of oil
(n=8, 2 ug EB (n=8, 20 mg MER-25 (n=7), or 2 ug EB plus
20 mg MER-25 (n=7). Food intake was measured daily, and
7
body weight was measured on days 3, 6, and 10 of treatment.
Vaginal. smears were taken daily beginning on the 3rd day
of treatment. Sexual behavior was tested during the dark
on days 2, 5, 9, and 10. For testing on the last day,
500 ug of progesterone was injected k hours prior to testing.
The response of the female was rated on a scale of 0-3
after Powers and Valenstein (1972). The receptivity score
was the average response to 10 vigorous mounts. At the
end of treatment all animals were given an overdose of
sodium pentobarbital and the uterus was removed, cleaned
of fat and mesentery, blotted and weighed to the nearest
1 mg. Naso-anal length was also measured.
Results
Part 1. Pood intake comparisons were based on indivi-
dual means during the 3rd week when the oil group's food
intake had stabilized above pre-operative levels. EB
caused a reduction of foo d intake by more than i| g/day,
t(8)=3.68, p<.01. Table 1. MER-25 produced no attenuation
of EE's effect. The EB plus MER-25 group ate slightly less
than the EB group and 5 g/day less than the oil control,
t{7)=3.70, p<.01. The effects of the EB and MER-25 on
food intake were not additive at this dose, since the MER-25
group ate the same amount as the EB plus MER-25 group.
Estrogen antagonism was likewise not seen for body weight
effects (Table 1) the effects of EB and MER-25 were
additive. The EB plus MER-25 group gained less than the
MER-25 group, t(7)=2.l4.8, p<.05. MER-25 caused a significant
Table 1. Effects of estradiol benzoate (EB, 2 ug/day)
,
MER-25 (5 mg/day), EB (2 ug/day) plus MER-25 (5 mg/day)
,
and oil vehicle on daily food intake during the third
week of treatment and body weight gain during 22 days of
+
treatment. (Mean - standard error of the mean)
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suppresion of body weight, t (8)=5.53, P<.001, which did
not differ significantly from that produced by EB. The
5 mg dose of MER-25 did not clearly inhibit EB induced
sexual behavior. It did however inhibit the uterina
weight increase (EB-treated: 558 mg vs. EB plus MER-25:
31k mg, t(7)=2128, p<.05, one-tailed) and completely
prevented uterine ballooning.
Part 2. MER-25 at the higher dose also showed no
antagonism of estrogen-induced changes in weight regulation,
in contrast to the inhibition of all other somatic and
behavioral parameters examined (Table 2 and Figure 1). The
combination of MER-25 and EB caused greater reduction of
food intake than either drug or hormone alone. Animals
receiving both ate significantly less than the EB group,
t(l3)=i;. 55, p<.001, or the MER-25 group, t(12)=2.19,
p <.05. Body weight showed a similar additive effect of
the hormone and antiestrogen. The EB plus MER-25 group lost
significantly more weight than the EB group, t(13)=3.97,
p-<.01, or the MER-25 group, t(12)=3.66, p< .01. Body
length was slightly suppressed by EB, t( 1[|.)=2
.85, p<.05,
and by MER-25, t{ 13)=2. Ol;, pZ..05, one-tailed. On the
other hand, all other estrogen sensitive parameters measured
|(howed inhibition by MER-25 and little or no estrogenic
effects from MER-25 aloneA^ The uterine weight response was
clearly inhibited,^ t( 13 ) =5. 75, p<.001, and vaginal cornifi-
cation u&s reversed. The vaginal response was interesting
in that all animals receiving EB plus MER-25 initially had
11
Table 2. Effects of estradiol benzoate (EB, 2 nyg/day) and
MER-25 (20 mg/day) alone or in combination on various
estrogen-sensitive parameters. (Mean - standard error of
the mean)
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Figure 1. Effect of estradiol benzoate (EB, 2 ug/day)
and MER-25 (20 mg/day) alone or in combination on
body weight and food intake of ovariectomized female
rats. Arrow indicates beginning of treatment.
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comified smears within 3 days of treatment but the smears
contained only diestrous leucocytes after 5-6 days of
treatment. Similar delayed inhibition has been reported
for another antagonist, ICI k^.klk (Emmens, 1971). Smears
of animals receiving only MER-25 has predominantly leuco-
cytes and occasional scattered nucleated and cornified
cells. Sexual behavior was also inhibited by this dose of
MER-25, whether induced by EB alone, t(13)=1.88, p
one- tailed, or EB facilitated by progesterone, t(l3)=2.92,
p A.05.
EXPERIMENT 2. TRANSIENT REDUCTION OF FOOD INTAKE AND
PERMANEITT REDUCTION OF BODY WEIGHT BY MER-25
Part 1 of this experiment was designed to demonstrate
that MER-25 does depress food intake and body weight in
OVX rats and to determine whether the reduction of food
intake by MER-25 is transient, as estradiol- induced hypo-
phagia is. Part 2 determined the minimum effective dose
of MER-25 required to decrease food intake and body weight.
Procedure
Part 1. Twelve female rats weighing approximately
250 g were ovariectomized and allowed lj.2 days for food
intake to restabilize. They were then divided into two
groups (n=6) balanced according to baseline food intake
and body weight and injected daily with 5 mg MER-25 in
0.1 cc sesame oil or with the vehicle alone. Pood intake
was measured daily and body weight was measured every
third day. Injections were continued for 32 days.
Part 2. Thirty-eight female rats were ovariectomized
18 days prior to the beginning of treatment. Groups (n=7
or n=8) received either MER-25 (5 mg, 1 mg, 500 ug or 100
ug) or iol vehicle daily for 20 days.
Results
Part 1. Food intake was significantly depressed by
MER-25 during days 5-21, t(10)=3.25, P<.01, (Figure 2).
Over the course of treatment eating returned to control
levels. During the final 10 days MER-25 treated animals
17
Figure 2. Effect of the antiestrogen MER-25 (5 mg/day)
and oil vehicle on body weight and food intake of
ovariectomized female rats. Arrow indicates
beginning of treatment.

19
ate an average of 26.6 g/day and controls ate 27.3 g/day,
t(10)=0.97, £<.35. All MER-25 treated animals increased
their food intake from the first 16 days to the last 10
days, t(5)=3.09, ^-t.OS, and during the last 10 days did
not differ significantly from their own baselines (27.5
g/day compared to 26.6 g/day, t(5)=0.73, R<^lvS). However,
the body weight of MER-25 animals remained constant and at
the end of treatment they had gained significantly less
than controls, t^( 10)=i|..[j.8, £<.01.
Part 2. Pood intake during days 6-20, computed as a
percentage of baseline food intake, was significantly lower
for the 5 mg MER-25 group compared to the oil-injected
controls, t_(13)=2.63, £^.05. The final body weight,
computed as a percentage of baseline, was also lower for
the 5 mg MER-25 group compared to oil controls, t_(13) =
I1..2I, 2^.01. One mg/day of MER-25 was totally ineffective
in decreasing eating and body weight, as were the 500 ug
and 100 ug doses. The 5 mg MER-25 group received injections
for an additional I6 days, and its mean food intake returned
to approximately that of the control group by the 31st day.
EXPERIMMT 3. ATTENUATION OF MER- 25- INDUCED REDUCTION
OF FOOD INTAKE AND BODY WEIGHT BY CONCURRENT
PROGESTERONE INJECTIONS
Since es tradiol-induced suppression of food intake is
inhibited by progesterone, the effects of progesterone on
MER-25-induced changes in food intake were investigated.
Both long-term ovariectomized rats whose weight had
plateaued and recently ovariectomized rats that were still
hyperphagic were tested.
Procedure
Part 1, Eighteen female rats were ovariectomized and
allowed 1^2 days for food intake and body weight stabiliza-
tion. Daily injections of oil, 5 mg MER-25, or 5 mg MER-25
plus 5 mg progesterone (n's = 6) were administered for 32
days.
Part 2. Seventeen female rats weighing an average of
250 g were ovariectomized. The following day injections
were begun of oil (n=5), 5 mg MER-25 (n=6) or 5 mg MER-25
plus 5 nig progesterone (n=6). The oil controls were con-
currently controls for Experiment 1, Part 1, Injections
were continued for 22 days.
Results
Part 1. Over the 32 day period, progesterone caused
a reversal of the effects of MER-25 on body weight since
the progesterone plus MER-25 group gained significantly
more than the MER-25 group (Table 3), t.(10)=2.83, £-t.05.
21
The effects of progesterone on MER- 25- induced reduction in
food intake were suggestive but not statistically reliable.
During the third week of treatment when MER-25 suppression
of food intake was maximal, t_(10)=3.91, ^<.01, progesterone
failed to clearly reverse the effect of MER-25, l(10)=1.55.
Part 2. In recently ovariectomized females progesterone
countered the effects of MER-25 on both food intake and
body weight (Table 3). During the third week of treatment,
the MER-25 plus progesterone group ate more than the MER-25
group, t{10)=1.97, £.^.05, one-tailed. The effects of
MER-25 on body weight were again attenuated by progesterone.
Over the course of treamtnet the MER-25 group gained less
than the MER-25 plus progesterone group, t_(10)=l,82, £-C.05,
one-tailed.
22
Table 3. Effects of MER-25 (5nig/day), MER-25 (5 mg/day)
plus progesterone (5 mg/day), and oil vehicle on daily
food intake during the third week of treatment and body
weight gain during treatment. In Part 1 females were
ovariectomized 1^2 days prior to treatment and injected
for 32 days. In Part 2 females were ovariectomized one
day prior to treatment and injected for 22 days. (Mean
- standard error of the mean)
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EXPERIMENT I4.. SEX DIFFERENCE IN RESPONSIVENESS
TO MER-25 .
Since estradiol is more effective in suppressing food
intake and body weight in famales than in males (Gentry
and Wade, 1976b), this experiment examined the possibility
of a sex difference in responsiveness to MER-25. To
avoid confounding weight differences with sex differences,
two groups of females were used, one of comparable age to
the males and one of comparable body weight.
Procedure
Eight male rats castrated 3-i|. weeks prior to the
beginning of treatment averaged 338 g in body weight. The
ten light females of comparable age were ovariectomized
15 days before treatment and averaged 291 g when injections
began. The eight heavy females had been ovariectomized
3 months earlier and weighed an average of 352 g. Half
of the animals in each group were injected daily with
oil and the other half with 10 mg MER-25 for 28 days.
Results
A comparison of same age castrated males ajid females
indicated that MER-25 affected the body weight of females
more than males (Figure 3; an overall analysis of variance
was performed on percentage weight change during 28 days
of treatment and subsequent two-way analysis of males and
light females resulted in a significant Sex X Drug inter-
action, F(l,20)=l|.53, £<.05). Males and females of the
25
Figure 3. Effects of MER-25 (10 mg/day) and oil vehicle
on body weight of castrated male rats, ovariectomized
female rats of comparable age (light females), and
ovariectomized female rats of comparable weight
(heavy females).
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same initial weight appeared to be comparably affected;
the initial weight appeared to be comparably affected; the
females showed a decrease in weight whereas the males'
weight gain only slowed, but in comparison with their
own controls there was no sex difference. The sex
difference in the effects of MER-25 on food intake was less
ambiguous. Females were more strongly affected than males,
regardless of initial body weight (Figure [j.) . Analysis
was performed on mean food intake during the first 10 days
of treatment as a percentage of baseline. Both light and
heavy females showed greater inhibition of food intake than
males (interaction term for males vs. light females, F(l,20)
=11.1^0, £-A.01; interaction for males vs. heavy females,
F(l,20)=8.85, p<.01). During the first 10 days of injec-
tions the MER-25 treated males ate 6^ less than their base-
line, MER-25 treated light females ate 17^ less than their
baseline, and MER-25 treated heavy females ate 36^ less than
their baseline.
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Figure l^.. Effect of MER-25 (10 mg/day) and oil vehicle
on food intake of castrated male rats, ovariectomized
female rats of comparable age (light females) and
ovariectomized female rats of comparable weight
(heavy females). Lower panel is the difference for
each condition from its respective control. Arrow
indicates beginning of treatment.
110 smm 9Z-U2\n *3wini aood
EXPERIMENT 5- CONTROL FOR ILLNESS: A LEARNED
AVERSION PARADIGM
An experiment was performed to ascertain whether the
food intake reductions could be accounted for by a general
illness possibly produced by MER-25 rather than a true
estrogenic effect.
Procedure
A learned aversion paradigm (Nachman, 1970) was
employed to investigate the possibility of the induction
of gastrointestinal discomfort. Twenty OVX females were
adapted to water's being available 30 min./day, beginning
2 hours after the onset of dark. Water intake was measured
to the nearest ml in calibrated Richter tubes, and food
intake was measured daily. Saccharin flavored (0.1^)
water was presented as a novel taste, and followed at the
end of the 30 min. period by a subcutaneous injection of
lithium chloride (3.0 mEq/kg, i.e., 7.5 ml/kg of .I4. M
LiCl, n=7), MER-25 (125 mg/kg in oil, n=7), or oil (equi-
volume to the MER-25 injections, n=6). On the following
two days water was presented, and on the third day a
second saccharin- injection pairing was made. Following
the second pairing, 9 days were allowed for the disappearance
of the direct effects of the MER-25 (a food intake decrease),
so that any learned effects would be measured rather than
direct drug effects. The LiCl group controlled for the
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possibility that a learned aversion would fade during this
time.
Results
MER-25 failed to produce a learned aversion to the
taste of saccharin after one or two pairings (Figure 5);
the oil and MER-25 groups drank virtually identical amounts
in the two tests (21.0 vs. 19.8 ml on the first test and
21.0 vs. 21.1 ml on the second test. LiCl in the same
paradigm produced a highly significant reduction in saccharin-
water intake on both test, i(ll)=6.99, p-^.OOl and t(ll) =
12.50, p^.OOl. The dose of MER-25 was approximately 10
times the daily dose required to reduce food intake, and
caused a significant reduction in food intake after both
injections. The change of food intake of oil and MER-25
treated rats for the two days pre- and post-injections
differed significantly, t ( ll)i|.. 614., p-^.OOl. After the
second injections, food intake remained depressed for 6
days, t(ll)2.11, p^.05, one-tailed. Body weight was also
clearly affected after the second injection; final body
weight of oil and MER-25 injected rats differed significantly,
t(ll)=3.59, p^.Ol. Water intake was not reliably affected.
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Figure 5. Effects of two injections (Inj) of oil, MER-25
(125 mg/kg), or lithium chloride (LiCl, 2.0 mEq/kg)
following 30 min. presentations of saccharin-flavored
water (S, 0.1^ saccharin). Upper panel is food
intake. Lower panel is consumibion during daily 30
minute periods of unflavored water (connected by
solid lines) or saccharin-flavored water (indicated
by arrows and connected by dotted lines).

EXPERIMENT 6. CENTRAL EFFECTS OF MER-25 ON EATING
This experiment determined whether an antiestrogen
implanted in the hypothalamus would produce effects on
eating similar to those produced by estradiol.
Procedure
Female rats were ovariectomized and later stereo-
taxically implanted with bilateral, concentric double-
walled stainless steel cannulas (2? inner gauge, and 22
outer gauge). Operations were performed under sodium
pentobarbital anesthesia. Cannulas were aimed just dorsal
to the ventromedial hypothalamus, anterior hypothalamus
(AH), or preoptic area (PCA). After recovery and the
recording of a stable baseline of food intake, the inner
cannulas were removed and crystalline MER-25, cholesterol,
estradiol or EB was tamped into the lumen. The chemical
was left in place for three days, and then the inner
cannulas were removed and clea ;ied by cumbustion. After
at least a week of restabilized baseline, another chemical
was implanted for an additional three days. All rats
received at least MER-25 and cholesterol in random order.
Pood intake was measured daily to the nearest .1 g.
Results
An animal was considered to have responded to a
treatment if its mean food intake during the three days
following implantation of the chemical was at least 10^
less than its food intake during the three days prior to
Implantation. Four animals were eliminated from analysis
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because they responded to cholesterol (two VMH and two AH
placements); a fifth animal was eliminated because of
hyperphagia apparently due to mechanical damage of the VMH.
A total of 10 animals responded to MER-25 but not to choles-
terol. Histological examination indicated that in 6 of
these the tips of the cannulas had been located in or dorsal
to the VMH (Figure 6); a seventh effective placement was
at the same rostral-caudal plane but more lateral. Place-
ments of the other 3 effective cannulas were in the POA
and the bed nucleus of the stria terminalis (POA-ST).
There were 5 ineffective POA-ST placements and 6 ineffective
anterior hypothalamic placements. One animal had a place-
ment close to the arcuate nuclei and failed to respond to
MER-25. Statistically, responses to MER-25 implanted in
the ventral hypothalsimus differed from those in the AH-POA-
ST (Fisher test, p^.OOl).
Four of the animals with VMH placements effective for
MER-25 were implanted with EB or estradiol; all four decreased
their food intake. EB was also effective in the arcuate
placement which did not respond to MER-25. Of the remaining
non-responders to MER-25, 6 were implanted with EB or
estradiol, and none responded by decreasing food intake.
The animals with effective placements in the ventral hypotha-
lamus decreased their food intake an average of 22^ to
MER-25 and the average response to estradiol or EB was a
19% reduction in food intake. The three effective place-
ments in the POA-ST caused greater reductions, averaging
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Figure 6. Location of implants of antiestrogen which
affected food intake in female rats. Squares indicate
locations of bilateral implants of MER-25 which caused
a reduction of food intake of at least 10% for the
three days following implantation and showed no
response to cholesterol implantation. Circles
indicate location of implants which did not alter
food intake. Coronal planes of the rat diencephalon
are adapted from Pellegrino and Cushman,
responded to MER-25
OnO response to MER-25
EXPERIMENT ?. BODY WEIGHT EFFECTS OP MER-25 INDEPENDENT
OP POOD INTAKE CHANGES: A PAIR-FEEDING STUDY
This experiment determined whether some of tte body
weight reduction caused by EB or MER-25 treatment is mediated
by factors other than reduction of food intake.
Procedure
Twenty-five female rats were ovariectomized 15 days
prior to treatment. Twenty females were divided into 10
pairs matched for body weight, and these 10 pairs were
divided into 2 groups balanced for body weight (mean body
weight 281 g for all I4. groups). One member of each pair
in group 1 received 5 ug of EB and was fed ad lib; the other
member received oil injections and was allocated the amount
of food consumed on the previous day by its matched pair.
Similarly, five animals received 10 mg MER-25 daily and food
ad lib while a pair-fed group received oil injections and
individually tailored food allotments. The five remaining
rats (average body weight 270 g) received oil injections
and ad lib food. Body weight was measured every third day
and injections were continued for 33 days.
Results
Both EB and MER-25 caused weight reductions which could
not be simulated simply by food restriction in controls
(Figure 7). Whereas animals injected with EB increased
body weight by animals which ate the same amount but
were injected with oil increased body weight by lS%, paired
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ure 7. Percentage body weight changes of ovariectomized
female rats treated with 5 ug estradiol benzoate (EB)/
day, IQ mg MER-25/day or with the sesame oil vehicle.
Two additional groups were treated with sesame oil and
pair- fed with either the EB- or MER-25- treated groups.
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t{k)=9.3S, p<C.01. Neither of the pair-fed groups differed
significantly from the ad lib oil controls.
It could be argued that a metabolic derangement or som.
other consequences of pair-feeding, per se, prevented the
expected weight losses of the pair- fed rats. However, it
has been shown that a pair-feeding regimen similar to ours
produces weight losses, not gains, in rats (Rider and Chow,
1971). Thus, the body weight differences are not likely
artifacts of a pair-feeding procedure.
EXPERIMENT 8. EFFECTS OF MER-25 IN GERBILS
Female Mongolian gerbils are unusual in that they
respoid to EB injections by increasing eating and body
weight (Maass and Wade, unpublished); they therefore
provide a particularly good opportunity to test the
generality of the estrogenic effect of MER-25 on eating.
If gerbils responded to MER-25 by increasing their food
intake, it would demonstrate that MER-25 can produce
estrogenic effects on food intake which cannot be con-
founded by hypothetical toxic effects.
Procedure
Five weeks after ovariectomy 30 adult gerbils were
divided into four groups. Daily subcutaneous injections
of the following compounds were administered for four
weeks: k mg MER-25 (M; n=7), I; mg MER-25 plus 1 mg pro-
gesterone (MP; n=8), l\. mg MER-25 plus 2 ug EB plus 1 mg P
(MEP; n=7), or the sesame oil vehicle (0; n=8). All
djections were in 0.1 ml. The effects of MER-25 in com-
bination with P and EP were of interest, since in OVX
gerbils progesterone augments the effects of EB on eating
while having little or no effect when given alone (Maass
fiind Wade, unpublished). The MP group might facilitate
detection of an estrogenic effect of MER-25, whereas the
MEP group would optimize the chances of observing an anta-
gonistic action of MER-25. Analyses were performed on the
difference between individuals' mean food intake or body
i+3
weight during the second 2-week period of treatment and a
2-week pretreatment baseline. Data from Maass and Wade
(unpublished) of additional control animals {n=6) and animals
given progesterone (1 mg; n=6) were added to the analysis
to allow two-way analysis of variance of the 0, M, MP, and
P groups. Data of groups receiving E and EP are presented
for comparison.
Results
The results indicate that MER-25 (M and MP) causes
increasing eating and body weight in OVX gerbils, P(l,31)=
i;.778, P-C.05, and P( 1, 31) =l4..9i4i, p<.05 (Table i^) . This
is presumably an estrogenic effect, since estradiol benzoate
also increases eating and body weight in gerbils. Pro-
gesterone did not have any effect alone and did not interact
with the effect of MER-25 on either measure. The three
compounds together (MEP) markedly increased eating and body
weight, t(19)=5.227, p^.OOl and t(19)=6. 525, p< .001.
There was no evidence of an es trogen-stntagonizing effect on
these measures from a comparison of the MEP and EP groups.
The effects of the ovarian hormones and the antiestrogen
on body weight continued as long as treatment continued,
aid after treatment was discontinued the animals' body
weights returned to control levels within seven weeks.
kh
TABLE I4.. POOD INTAKE AND BODY WEIGHT OP MONGOLIAN GERBILS
TREATED WITH THE ANTIESTROGEN MER-25 AND OVARIAN
HORMONES
Ovariectomized gerbils were given daily injections of MER-25
(M, ij. mg), MER-25 plus progesterone (MP, k mg plus 1 mg),
MER-25 plus estradiol benzoate plus progesterone (MEP, i; mg
plus 2 ug plus 1 mg), or sesame oil vehicle. Data are
computed as change from 2 weeks of baseline to weeks 2-I|.
of treatment.
*Data of similarly treated animals from Maass and Wade
(unpublished)
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DISCUSSION
Estradiol and the antiestrogen MER-25 have similar
effects on eating and body weight in rats and gerbils:
(1) The food intake reduction during EB or MER-25 treatment
is transient; eating remains depressed for a period of days
and then gradually returns to control levels, but body
weight remains lower than controls (Experiment 2). The
time-course of the reinstatement of normal food intake
levels varies, depending on the dose of MER-25 and pre-
treatment body weight, but is approximately 30 days, similar
to that found for EB treatment (Wade, 1975).
(2) Progesterone inhibited the effects of MER-25 as it
does those of EB (Experiment 3). In recently ovariectomized
females 5 nig of progesterone caused a S0% inhibition of
the food intake suppression by MER-25, comparable to the
effects of 5 nig progesterone counteracting 2 ug of EB
(Gentry and Wade, 1976a). In heavier long-term ovariec-
tomized females progesterone produced a similar, but not
statistically significant, effect on food intake, and the
effect of MER-25 on body weight was significantly attenuated
by progesterone,
(3) MER-25 is more effective in female rats than in
male rats in causing food intake reduction (Experijnent i^.)
.
There are similar sex differences in the effectiveness of
EB for a variety of behaviors including eating (Gentry and
Wade, 1976b; Pfaff, 1970). The sex difference in food
^7
intake effects was clear for either light or heavy females
compared to males, but the sex difference for body weight
effects was apparent only for the light females compared
to males.
(k) When rats were implanted intracerebrally with the
antiestrogen, the medial basal hypothalamus was an area
in which MER-25 produced estrogenic actions on eating. For
all 11 animals implanted with the antiestrogen and with
estradiol at another time, there was a high correlation
between responses to the antiestrogen and to the estrogen.
Although the POA-ST placements were not tested with estradiol,
it is less likely that the 3 responsive sites were actually
estrogenic sites, since there were 5 ineffective implants in
similar sites. The finding that the most consistently
effective placements were in the medial basal hypothalamus
confirms earlier reports on the localization of estradiol's
actions on food intake (Beatty et al., 197I|.; Jankowiak and
Stern, 197i;; Wade and Zucker, 1970).
(5) Both EB and MER-25 produce some body weight reduc-
tions by means independent of their alterations in food
intake (Experiment 7).
(6) The results of Experiment 8 with gerbils extend
across species the parallel between the effects of EB and
MER-25 on food intake. In rats estrogens and MER-25
decrease food intake and body weight, whereas in gerbils
the estrogenic effect is indicated by the increases in
food intake and body weight during treatment with MER-25.
1+8
For a number of reasons it is highly unlikely that
MER-25 is having its effects on eating and body weight
by inducing a nonspecific malaise:
(1) An aversion to the novel flavor of saccharin was
not induced by twice pairing it with a very high dose of
MER-25 (Experiment 5). The effectiveness of the LiCl
treatment suggests that if any aversion had been created
by MER-25 it would still have been evident at the final
testing.
(2) MER-25 does not alter spontaneous running wheel
activity levels of nonhormone-treated rats. Although MER-25
reduces estradiol- or testosterone-induced activity in male
rats, it has no effect on the spontaneous activity of
castrated males (Roy and Wade, 1975). In that experiment
MER-25 did reduce the males' food intake; during the first
k days of treatment MER-25 treated rats averaged Qk% of
their baseline, t{8)=2.i;0, p-^. .05 (unpublished data).
(3) The food intake reduction is transient while the
body weight reduction is permanent.
Within each experiment there was a tendency for
MER-25 to have greater effects in heavier rats; for example,
in Experiment l|. there was a high correlation between baseline
weight and weight loss (r=.70 for long-term OVX females and
r=,82 for recently OVX females). This suggests a weight
regulatory effect rather than an illness effect, since the
latter explanation would product greater effects in lighter
rats because they receive relatively higher doses.
k9
(5) The increases in eating and body weight produced
by MER-25 in gerbils (Experiment 8) also suggest that the
effects in rats are specifically estrogenic.
(6) Finally, MER-25 can reduce food intake when
implanted durectly into the hypothalamus (Experiment 6).
These data support the hypothesis that MER-25 is acting as
an estrogen to lower food intake and body weight rather
than by causing general illness. The results of hypothalamic
implants indicate that the effects on eating of either MER-25
or EB are centrally mediated, but pair-feeding studies
indicate that there are additional metabolic effects of
both agents which cause further loss of weight (Experiment
7).
MER-25 is totally ineffective in antagonizing the
effects of estradiol on eating and body weight (Experiment
1). Niether 5 mg nor 20 mg of MER-25 attenuated the effects
of 2 ug of EB on eating and body weight at any time, yet
it inhibited Eb's effects on sexual behavior, uterine weight
and vaginal smears. The inhibition by MER-25 of these
responses is well-established (Lerner et al., 1958; Meyerson
and Lindstrom, 1968; Sodersten, I97I4.)
. Furthermore, MER-25
alone had no agonistic effects on these noneating parameters.
This is consistent with other reports of the absence of or
minimal agonistic effects on these measures (Komisaruk and
Beyer, 1972; Lerner, 1961;; Lerner et al., 1958; Torenius,
1971). There have been no reports of any induction of
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female sexual behavior by MER-25, despite a wide variety of
doses and timing routines tested (Meyerson and Lindstrom,
1968; Sodersten, 1971+; Hoy, unpublished data) and no
evidence of an estrogenic effect on spontaneous activity
(Roy and Wade, 1975). In gerbils, the similar increases
in eating and body weight of the MEP and EP groups support
the idea that MER-25 does not have any estrogen-antagonizing
effects on these measures.
Thus, the estrogen-sensitive systems affecting eating
and weight regulation differ biochemically from most other
behavioral and peripheral systems, as reflected by the
difference in responses to antiestrogens • The distinction
is not simply that the antiestrogen is estrogenic, since
other systems may sometimes exhibit some agonistic response
under the appropriate conditions. The distinction is that
the eating system shows a fully estrogenic response to the
antiestrogen, so that no inhibition of estradiol's action
can be demonstrated. Preliminary evidence indicates that
the other triphenyl antiestrogens are similarly estrogenic
with respect to eating, including CI-628 (Powers, personal
communication) and nafoxidine (Roy, unpublished data).
Recent reports (Baum and Vreeburg, 1976; Sodersten, 197i4-)
indicate that MER-25 may also be solely "estrogenic" with
respect to masculine sexual behavior. Mounting behavior is
induced by EB or MER-25 in castrated rats of either sex,
and the drug fails to inhibit EB- induced mounting in
females or testosterone-induced mounting in males. Thus,
estrogens are able to influence behavior by at least two
different mechanisms as indicated by the responses of
various behaviors to antiestrogens
. The manner in which
estradiol's actions on the eating system differ from its
actions on other behavioral systems is unknown, but would
presumably be related to the mechanism of action of the
antiestrogens
•
PART^II.. THE EFFECTS OF ANTIESTROGENS ON THE UPTAKE OF
H-ESTRADIOL IN THE CENTRAL NERVOUS SYSTEM AND
FEMALE SEXUAL BEHAVIOR
Antiestrogens may produce their estrogen-antagonizing
effects by forming relatively ineffective complexes with
estrogen receptors, thereby lowering the estradiol uptake
into target tissues. Their estrogenic actions could also
be mediated by interactions with estrogen receptors. It
is appropriate to begin an investigation of either the
estrogen-antagonizing actions or estrogenic actions of
antiestrogens by determining whether or not they interact
with estrogen receptors, as indicated by competition with
estradiol for binding sites. Competition for estrogen
receptors of peripheral tissues has been clearly demonstrated
(Black and Kraay, 1973; Jensen et al., I966; Stone, 1961].;
Terenius, 1971; Whalen and Gorzalka, 1973), but reports
concerning the effects of antiestrogens on brain estradiol
uptake have been less consistent. Hypothalamic uptake of
estradiol was reportedly not reduced by the antiestrogen
CI-628 (Perry et al., 1973), even in a paradigm similar to
one in which estrous behavior was inhibited (Whalen and
Gorzalka, 1973). However, there have been recent reports
of in vivo competition by CI-628 in the cytosol fraction
(Whalen et al., 1975) and nuclear fraction (Chazal et al.,
1975; Luttge et al., 1976) of the hypothalamus. Inhibition
in the nuclear fraction may be particularly important if
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estradiol acts by similar mechanisms in the brain and uterus.
Nafoxidine is an antiestrogen widely used to study mechanisms
of estrogen antagonism in the uterus (Capony and Rochefort,
1975; Clark et al., 1971;; Jensen et al., 1966; Katzenellen-
bogen and Ferguson, 1975). Its behavioral effects have
not been studied, and there have been positive (Eisenfeld
aid Axelrod, I967) and negative (Jensen et al., I966) reports
on its inhibition of hypothalamic estradiol uptake. The
antiestrogen clomiphene competes with estradiol in the
hypothalamus in vivo (Eisenfeld and Axelrod, 1967; Kato
et al., 1968; Maurer and Woolley, 1971), but conclusions
from these data regarding the mechanisms of estrogen-
antagonism must be limited, since these studies have
employed racemic clomiphene, one isomer of which is a full
estrogen (Ross et al., 1973). MER-25 is a commonly used
antiestrogen in studies of sexual behavior (Baum and Vreeburg,
1976; Komisaruk and Beyer, 1972; Meyerson and Lindstrom,
1968; Sodersten, 197)-|) . In vitro MER-25 has a low affinity
for hypothalamic cytosol estrogen receptors (Barley et al.,
1971;), but it has not been tested for its effects on hypo-
thalamic estradiol uptake _in vivo .
In order to clarify the relationship between estradiol
binding in the brain and its behavioral actions, the effects
of three anties trogens (MER-25, CI-628, and nafoxidine) on
the in vivo ^H-estradiol uptake and retention were determined
in cell nuclear fractions of regions of the brain and
pituitary. In parallel studies their ability to block
estradiol-induced female sexual behavior was examined.
H-estradiol Uptake
. Mature female Sprague-Dawley
rats (Charles River Breeding Laboratories), housed in grou
cages under a 12:12 lighting cycle, were ovariectomized at
least four days prior to uptake studies. Groups were
6, ]J - H-estradiol-17B (specific activity: 91.3 Ci/mM;
New England Nuclear) was dissolved in 20% ethanol. Injec-
tions of 100 uCi (.3 ug) in .2 ml were administered in the
femoral vein under light metho^yflurane (Metofane) anesthesia.
MER-25 (1+0 mg, in sesame oil), CI-628 (i^. mg, in saline),
nofoxidine (I4. mg, in sesame oil), or sesame oil was injected
intraperitoneally at various times before or after the
^H-estradiol injection. Doses of antiestrogens were based
on the finding that i+O mg of MER-25 are required to inhibit
mating in intact female rats, (Shirley, Polinsky, and
Schwartz, I968) and CI-628 and nafoxidine have approximately
10 times greater affinity than MER-25 for uterine estradiol
receptors (Black and Kraay, 1973; Terenius, 1971). At
various times after the estradiol injection, rats were
anesthetized with sodium pentobarbital (Nembutal), a blood
sample was taken, and the animals were perfused with cold
saline
.
Method
matched for body weights.
55
Cell nuclei were isolated by the method of Zigmond and
McEwen (1970) with modifications (Gentry, Wade, and Roy,
1976). All samples were homogenized in cold buffer con-
taining
.32 M sucrose,
.25^ Triton X-100, 3 mM MgCl^, ImM
K^PO^, pH 6.5. An aliquot of this was taken as the whole
homogenate. The remainder was centrifuged at 850 ^ for 10
min., and washed once in the same buffer without Triton.
After purification of the nuclei by centrifugation through
buffer containing 2 M sucrose, radioactivity was extracted
with 3 X [j. ml toluene-based scintillation cocktail. Protein
was precipitated with ethanol and estimated by the method
of Lowry et. al. (1951). Results are expressed as the ratio
of tissue to plasma, i,e
. . disint./min./mg. protein divided
by bloo.d plasma disint./min./ ul. All differences reported
are significant at the .05 level or beyond using the Student's
i-test. The results were the same whether or not the data
were standardized by dividing by plasma levels of radio-
activity.
In vitro Dissociation
. For this experiment animals
were treated as above with sesame oil or l\.0 mg MER-25 2
3hours prior to H-estradiol and were killed 2 hours after
the estradiol injection. The nuclei were isolated as
above, but POA and hypothalajnic sections were pooled.
Isolated nuclei from 8 animals per group were resuspended
in the .32 M sucrose buffer without Triton and incubated
o
at 27 • Aliquots were taken at various times, washed 3
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times in cold buffer, and the radioactivity extracted.
The supernatant from the washes (radioactivity not bound
to nuclei) was counted in toluene scintillation cocktail
containing 33^ Triton X-100. Results are expressed as the
percentage of the total radioactivity (supernatant disint./
min. plus pellet disint ./rain. ) found in the pelleted nuclei
(percent bound)
.
Behavioral Testing;. Three ug of unesterified estradiol-
17B in 20^ ethanol were injected intravenously 21; or 36
hours before
-testing. Progesterone (1 mg) was injected
subcutajieously 5 hours prior to testing. Groups were matched
for behavioral sensitivity to estradiol. Anties trogens (MER-25,
kO mg; CI-628, mg; nafoxidine, i^. mg) or vehicle were
injected intraperitoneally 2 hours prior to the estradiol
injection, except for one study in which MER-25 ik-O mg) was
injected 12 hours prior to the estradiol injection. The
female was placed into a circular arena, and then two
sexually experienced males were placed in the arena and
allowed 10 vigorous mounts. Lordosis responding was rated
on a 3-point scale after Powers and Valenstein (1972), 3
being the highest score and indicating extreme dorsoflexion
of the head and rump. Observations were made without know-
ledge of the treatment received by particular animals.
Animals used in the MER-25 studies were tested repeatedly
with at least one week intervening between sessions and
alternating control and experimental treatments, without
detriment to the lordosis responding of control groups.
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Student's t-test was used to determine statistical signifi-
cance. The results were identical when the data were
expressed as lordosis quotients.
EXPERIMENT 9. EFFECTS OF ANTIESTROGENS INJECTED
2 HOURS PRIOR TO ^H-ESTRADIOL ON UPTAKE IN
WHOLE HOMOGENATES AND CELL NUCLEI
OP THE BRAIN
Two -hour uptake.
When uptake was examined 2 hours after the injection of
3H-estradiol, the antiestrogen CI-628 most effectively
reduced levels of radioactivity (Figure 8). Uptake was
reduced in the whole homogenates of pituitary and all three
brain areas. Nuclear ^H-estradiol binding was reduced even
more than whole homogenate binding, with 99/^ inhibition in
the pituitary, 79^ inhibition in the hypothalamus, 8?^ inhi-
bition in the POA, and 59/^ inhibition in the cerebral cortex.
Nafoxidine also effectively reduced ^H-estradiol uptake
in the pituitary and brain (Figure 8). It was somewhat
less effective than CI-628. Nafoxidine inhibited H-estradiol
uptake in the nuclear fraction by 88^ in the pituitary,
in the hypothalamus, and in the POA. MER-25 on the
3
other hand, failed to inhibit the 2-hour uptake of H-estra-
diol into any of the brain areas, even while inhibiting
pituitary uptake by 62,% in the whole homogenate and 70%
in the nuclear fraction (Figure 8). There was also no
inhibition of ^H-estradiol levels in hypothalamic cytosol
from similarly treated animals.
Six-hour and twelve-hour retention.
It has been suggested that for uterine tissue the low
levels of estradiol which are bound in cell nuclei for long
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Figure 8. Effects of anties trogens injected 2 hours prior
to ^-estradiol on levels of radioactivity in sub-
celular fractions of brain tissues and pituitary 2 or
12 hours after the ^H-estradiol injection. Mean
values
- S.E. of the concentration of tissue radio-
activity relative to plasma radioactivity are presented
for whole homogenate and cell nuclear fractions of
cerebral cortex (CTX), hypothalamus (HTH), preoptic
area-septum (POA), and pituitary (PIT). Intraperi-
toneal injections of sesame oil vehicle {n=[|. for 2-hour
and n=6 for 12 hour), MER-25 {^.0 mg in oil, n^ii for
2-hour and n=6 for 12-hour), CI-628 (i| mg in saline,
n=l^ for 2-hour and n=3 for 12-hour), or nafoxidine
(i^. mg in oil, n=i; for 2-hour and n=k. for 12-hour)
were administered 2 hours prior to an intravenous
injection of 100 uCi (.3 ug) of ^H-estradiol.
^5-pZ.
.05, -:t4:-p <,01
BRAIN. TISSUE /PLASMA
N A 9>
§ 8 §
BRAIN, TISSUE /PLASMA
2
CO
r-
>9
P:TUITARY, TISSUE/ PLASMA
BRAIN. TISSUE / PLASMA
PITUITARY, TISSUE/PLASMA
BRAIN, TISSUE/ PLASMA
—
(
>O
o
CO
O
"n
c
-I
m
>
o
3)
m
o
o
X
I
m
en
H
>
O
PITUITARY, TISSUE/PLASMA PITUITARY, TISSUE / PLASMA
61
time intervals may be functionally significant (Clark and
Peck, 1976). We investigated levels of bound radioactivity
at later time intervals after the injection of ^H-es tradiol
,
without changing the 2-hour interval between the antiestro-
gen and %-estradiol injections. At 6 hours after the
injection of estradiol, MER-.25 still showed no evidence of
inhibiting brain %-estradiol binding in either whole
homogenate or nuclear fractions, even through pituitary
nuclear radioactivity was reduced by 8l^,
Interestingly, by 12 hours after the ^H-estradiol
injection MER-25 had reduced radioactivity found in hypotha-
lamic nuclei by 26^ and lowered POA nuclear radioactivity
by (Figure 8). Whole homogenate levels in brain
tissues, which were quite low at this time, were not affected
by MER-25. Pituitary binding of estradiol at 12 hours was
reduced by MER-25 by 9irf in whole homogenate and by 96^
in nuclei.
Comparison of 2-hour uptake and 12-hour retention.
In addition to the appearance of significant inhibition
of brain nuclear ^H-estradiol binding by MER-25 after a long
time interval, CI-628 and nafoxidine showed a greater
inhibition of nuclear binding at 12 hours than at 2 hours
after the injection of estradiol. Figure 9 indicates that
when expressed as a percentage of control values, 12-hour
retention of H-estradiol was affected more than 2-hour
uptake for all three anties trogens . Percentages at 12 hours
and 2 hours differed significantly for all samples except
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Figure 9. Relative inhibition of
-^H-estradiol retention in
cell nuclei at 12 hours vs. at 2 hours. Data of
nuclear concentration of radioactivity from Figure 8
are expressed as percentage of control values at
the same time point. Twelve-hour percentages are
significantly lower than 2-hour percentages for all
samples except CI-628 pituitary and hypothalamus.
NUCLEAR ESTRADIOL
( Ti ssue/PlQsma)
CI.628 HTH and CI-628 PIT. CI-628 had already virtually
eliminated ^H-estradiol from pituitary nuclei at 2 hours.
EXPERIMENT 10. IN VITRO DISSOCIATION OF ^H-ESTRADIOL
PROM NUCLEI AFTER MER-25 TREATMENT
There are at least two possible explanations of the
greater inhibition of 12-hour retention than 2-hour uptake.
The first is that the anties trogens are somehow altering
nuclear binding sites so that estradiol is less firmly
bound, causing the hormone to leave the nuclei faster in
antiestrogen-pretreated tissues. The second is that continuing
competition of the estrogen and anties trogen occurs, and
the ratio of antiestrogen to estrogen might be greater at
later times. The first possibility was assessed by examining
the 221 vitro dissociation of H-estradiol from nuclei of
animals pretreated with MER-25 or oil and injected with
H-estradiol in the same paradigm as the above uptake
studies. If MER-25 were altering the ability of the nuclei
to retain the ^H-estradiol, ^H-estradiol should dissociate
from nuclei of MER-25 pretreated animals faster than from
control nuclei. At sacrifice 2 hours after the %-estradiol
injection there was again no inhibition of nuclear uptake
by MER-25 in the hypothalamus- POA. During 10 further hours
3
of in vitro incubation H-estradiol dissociated from nuclei
of the hypothalamus -POA at the same rate whether nuclei
were obtained from MER-25 treated animals or controls
(Figure 10). Pituitary nuclei also showed similar rates
of in vitro dissociation of 3h-estradiol when isolated from
MER-25 pretreated or control nuclei.
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Figure 10. In vitro dissociation of ^H-estradiol from brain
cell nuclei. Animals were treated as in Figure 8
(oil vehicle or i|0 mg MER-25 injected 2 hours prior to
.3
3ug H-estradiol) and nuclei prepared in the same
manner except hypothalamus and preoptic area were
pooled; tissues from 8 animals were prepared together.
The isolated nuclei were resuspended in the .32 M
sucrose buffer and incubated at 27° for specified
timr;-^; at these times aliquots of nuclei were removed
and washed three times. Radioactivity was determined
in the supernatants and final pellet of the washes,
and results are expressed as percentage of total
radioactivity bound to the pelleted nuclei.
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IN VITRO DISSOCIATION OF ^H-ESTRADIOL
FROM BRAIN CELL NUCLEI
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These results make the second possibility more likely:
competition for nuclear binding is still occurrin;^ lon/^
after the initial peak of binding. This would suggest that
the binding of estradiol to nuclei is a dynamic process,
with estradiol dissociating and reassociating with the
nuclei. This interpretation was encouraged by examination
of a logarithmic plot of the uptake and retention of
H-estradiol in control and MER-25 treated animals (Figure
11). The control groups deviate from the linearity which
characterizes simple second-order dissociation. While the
statistical interaction of time and treatment was signifi-
cant for all three tissues, a statistical analysis of the
nonlinear contribution to the control levels of estradiol
over time would require additional time points. MER-25 may
have replaced dissociating estradiol complexes rather than
allowing the possibility of reassociation.
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ure 11. Effect of MER-25 on nuclear retention of ^H-
estradiol. Data of animals given oil or I4.0 mg MER-25
two hours prior to ^H-es tradiol and killed 2 hours
(n's=l;) or 12 hours (n's=6) after the estradiol, and
animals given the same treatments and killed at 6 hours
(n's=3) are plotted in semilogarithmic coordinates.
The interaction of time and treatment is significant
for all three tissues.
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EFFECT OF MER-25 ON NUCLEAR RETENTION OF ^h-ESTRADIOL
TIME AFTER ^H-ESTRADIOL INJECTION, Hours
EXPERIMENT 11. MER-25 ADMINISTERED 12 HOURS PRIOR TO
3
H-ESTRADIOL
It is possible that MER-25 failed to inhibit 2-hour
uptake simply because it was not in the brain soon after
its injection and that the inhibition seen at 12 hours was
due to delayed competition with estradiol. To test this
hypothesis, MER-25 was injected 12 hours prior to an intra-
venous injection of ^H-estradiol, and 2-hour uptake was
examined again. In this paradigm uptake of H-estradiol
at 2 hours was significantly inhibited by MER-25 in nuclei
of all brain samples and whole homogenates of the hypotha-
lamus and POA (Figure 12). Pituitary nuclear optake was
reduced by 83^, hypothalamic nuclear uptake by 1^1%, POA
nuclear uptake by 1^0%, and cortical nuclear uptake by 31^.
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Figure 12. Effect of 12-hour MER-25 pretreatment on 2-hour
uptake of %-es tradiol
. MER-25 ([;0 mg; n=6) or oil
vehicle (n=6) was injected intraperitoneally 12 hours
prior to an intravenous injection of ,3 ug of -^H-
estradiol. Animals were killed 2 hours later and
radioactivity measured in whole homogenate and nuclear
fractions of cortex, hypothalamus, preoptic area-
septum, and pituitary.
EFFECT OF 12 HOUR MER-25 PRETREATMENT
ON 2 HOUR ^H-ESTRADIOL UPTAKE
- WHOLE HOMOGENATE
CTX HTH POA PIT
EXPERIMENT 12. DISPLACEMP2TT BY AN ANTIESTROGEN OP
^H-ESTRADIOL BOUND TO NUCLEI
A more direct test of the possibility that antiestrogens
can compete with normally exchanging estradiol was to
administer the antiestrogen subsequent to the peak of nuclear
estradiol binding and look for "displacement" of estradiol
at a later time. Peak nuclear concentration of ^H-estradiol
occurs 1-2 hours after a
.3 ug intravenous injection (Mowles,
Ashkanazy, Mix, and Sheppard, 1971). CI-628 was injected
intraperitoneally 2 hours following an intravenous injection
of ^H-estradiol, and the animals were sacrificed 12 hours
after the estradiol. Radioactivity retained in the brain
at this time was greatly reduced by CI-628 (Figure I3)
.
CI-628 subsequent to estradiol reduced the binding of
estradiol in whole homogenate of the hypothalamus-POA by
^Sio and reduced hypothalamic-POA nuclear binding by 83^.
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Figure 13
.
Displacement of H-estradiol from the hypotha-
lamus by a subsequent injection of an anties trogen.
CI-628 mg; n=i;) or saline vehicle (n=i;) was injected
intraperitoneally 2 hours after an intravenous injection
3
of
.3 ug -^H-estradiol. Animals were killed 12 hours
after the estradiol injection, and radioactivity
measured in whole homogenate and nuclear fractions of
cerebral cortex (CTX) and pooled hypothalamus-preoptic
area-septum (HTH-POA).
-«-p
.05, ""'•-p .01
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DISPLACEMENT OF 'h-ESTRAOIOL BY A
SUBSEQUENT INJECTION OF ANTIESTROGEN
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INHIBITION OP ESTRADIOL- INDUCED
LORDOSIS BY ANTIESTROGENS
The inhibition of behavior paralleled the inhibition
of nuclear binding of estradiol. Two-hour pretreatment
with CI-628 or nafoxidine, which produced substantial
reductions of nuclear estradiol levels, totally eliminated
female sexual behavior induced by an intravenous injection
of unesterified estradiol (Figure li|)
. The females were
active and readily mounted by the males, but they did not
display the lordosis reflex. On the other hand, MER-25
when injected 2 hours prior to the estradiol injection,
failed to inhibit early uptake of estradiol and also com-
pletely failed to inhibit sexual behavior tested at 21;
hours (Figure 15). There was also no significant inhibition
of sexual behavior when additional groups were tested at 36
hours after the estradiol injection. When tested at i|8 hours,
none of the 10 MER-25 treated animals was in heat, but only
i^. of 8 control animals were even marginally in heat. However,
when MER-25 was injected 12 hours prior to the intravenous
estradiol injection, a paradigm in which brain uptake was
reduced, clear inhibition of es tradiol-induced sexual recep-
tivity was observed at 2i| hours (Figure 15) •
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'6 li;. Inhibition of estradiol- induced female sexual
behavior by antiestrogens
. Ovariectomized-hysterec-
tomized rats were given intraperitonel injections of
sesame oil (n^l^), CI-628 (i^ mg in saline; n=i4.) , or
nafoxidine (Ij. mg in oil, n=l|) 2 hours prior to an
intravenous injection of 3 ug of unesterified estradiol.
At 19 hours after the estradiol, they were injected
subcutaneously with 1 rag progesterone, and at 2I4.
hours tested for sexual receptivity with a vigorous
male. The rating system is after Powers and Valenstein
(1972).
\
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INHIBITION OF ESTRADI OL - I N DU CED
SEXUAL BEHAVIOR BY ANTIESTROGENS
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Figure 1^. Effect of antiestrogen MER-25 on estradiol-
induced female sexual receptivity. Intraperitoneal
injections of oil vehicle or MER-25 (^0 mg in oil)
were administered either 2 hours or 12 hours prior to
an intravenous injection of 3 ug of unesterified
estradiol. Females were tested with males at either
21]. hours or 3^ hours after the estradiol injection;
1 mg progesterone was injected subcutaneously 5 hours
prior to testing. Oil or MER-25 injected 2 hours
prior to estradiol, for 2i;-hour test n's=3 and ii;
for 36=hour test, n's=13 and oil or MER-25
injected 12 hours prior to estradiol, n's=7 and 7.
*^'"P<»01
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EFFECT OF ANTIESTROGEN ON ESTRAD 10 L- 1 NDUCED RECEP Tl VITY
- MER-25 2 HOURS BEFORE ESTRADIOL
oil
MER-25
MER-25 12 HOURS
BEFORE ESTRADIOL
24 HOUR TEST
* »
36 HOUR TEST 24 HOUR TEST
DISCUSSION
These results clearly establish that ant ies trogens are
capable of inhibiting Vestradiol uptake in the hypothalamus
and preoptic area of the rat brain. With CI-628, inhibition
was most dramatic in the tissues with the highest uptake:
pituitary POA hypothalamus cortex. Competition by
unlabelled estradiol is also most evident in tissues with
highest uptake (McEwen and Pfaff, 1970). The inhibition of
H-estradiol uptake by a prior injection of CI-628 corro-
borates the finding of Chazal et al. (1975). In the present
study inhibition of the low levels of uptake in the cerebral
cortex was also found. This finding is consistent with
the previously demonstrated reduction of cortical nuclear
3H-estradiol binding by a prior injection of unlabelled
estradiol (Zigmond and McEwen, 1970; Roy and Wade, unpublished)
as well as autoradiographic evidence thatsome ^H-estradiol
binding occurs in this "non- target" tissue (Pfaff and
Keiner, 1973).
Nafoxidine and MER-25 are also capable of inhibiting
3the uptake of H-estradiol into the hypothalamus and pre-
optic area. Nafoxidine is less effective than CI-628, but
this may reflect the difference in injection vehicle
(sesame oil vs. saline) rather than a substantial difference
in affinity for neural estrogen receptors. The failure of
MER-25 to inhibit 2-hour uptake when given 2 hours before
3H-estradiol is probably due to solubility characteristics
83
of MER-25. MER-25 is not soluble in physiological saline,
whereas CI-628 and nafoxidine are. However, when MER-25
ikO mg) is given adequate time to reach the brain (12 hours),
it inhibits 2-hour uptake of %-estradiol to the same degree
as nafoxidine (i; mg) (Figure 1 cf. Figure , This delay
3in the inhibition of brain uptake of H-estradiol by MER-25
is relevant to the interpretation of experiments intended
to establish the time-course of the effects of estradiol by
using this antiestrogen (Shirley, Wolinsky, and Schwartz,
1968).
The finding that an injection of CI-628 2 hours after
an injection of
-^H-estradiol reduces the content of radio-
activity in the hypothalamus- POA 10 hours later is at
variance with an earlier report by Whalen and Gorzalka
(1973). These authors demonstrated that CI-628 subsequent
to an intravenous estradiol injection is capable of inhibiting
female sexual behavior, but they did not find significant
inhibition of hypothalamic H-estradiol uptake. We find
a SS% reduction of whole homogenate radioactivity and a
83^ reduction of nuclear radioactivity in the hypothalamus-
POA, This discrepancy is probably due to differences in
dosage: Whalen and Gorzalka used a lower dose of CI-628
for their uptake study (100 ug) than for their behavioral
study (1 mg.). This was rationalized on the grounds that
the estradiol dose was also lowered, from 1; ug to .3 ug.
However, an intravenous dose of .3 ug of estradiol or a
subcutaneous injection of .5 ug of estradiol more than half-
saturates nuclear binding in the hypothalainus (Anderson,
Peck, and Clark, 1973; Roy and Wade, unpublished), so lower-
ing the estradiol dose from I|. ug to
.3 ug probably does
not lower the es tradiol-receptor complex concentration by
10-fold. We used the same dose for behavioral and uptake
studies, i| mg, which was higher than the doses used by
Whalen and Borzalka,
The greater inhibition of 12 hour retention than 2 hour
uptake by both MER-25 and nafoxidine probably also reflects
displacement of estradiol by the antiestrogens
. Therefore,
it is likely that the brain cells which concentrate estradiol
do not differ in this respect from cells of the anterior
pituitary and uterus in which antiestrogens are capable of
displacing bound estradiol (Callantine, Clemens, and Shih,
1968; Whalen and Gorzalka, 1973). It is also likely that
unlabelled estradiol would be capable of displacing bound
3
H-estradiol in the brain as it does in the uterus (DeHertogh,
Ekka, Vanderheyden, and Hoet, 1971).
The functional significance of the low levels of bound
•^H-estradiol at long time intervals after injection has not
been clearly established or discounted. The RNA synthesis
inhibitor, actinomycin D, has been used to suggest a role
of genetic transcription in estradiol induction of sexual
behavior and positive feedback on LH release, and it effec-
tively inhibits these responses when given 12-13 hours after
estradiol (Jackson, 1973; Whalen, Gorzalka, DeBold, Quadagno,
PIo, and Hough, 197U) . CI~628 given up to 6 hours after
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estradiol completely blocks the induction of lordosis, and
some inhibition of lordosis is produced by injections as
late as l8 hours after estradiol, or 5 hours before testing
(Whalen and Gorzalka, 1973). Blaustein and Wade (unpublished)
have recently found that the period of estrous conditioning
produced by estradiol benzoate (EB) can be shortened by CI-
628 administered after the onset of sexual receptivity. Thus,
while the interval from the initial uptake of estradiol to
the appearance of its behavioral effects has been reasonably
well characterized (Green, Luttge, and Whalen, 1970), the
duration of estradiol's effects after it is removed from
brain cell nuclei needs further clarification. It is
possible that the low levels which are retained in nuclei
for at least 2i| hours after estradiol injections (McEwen,
Pfaff, Chaptal, and Luine, 1975) are exerting significant
effects for most of that time.
A comparison of the behavioral data with the uptake
studies shows that procedures which inhibit behavior also
inhibit brain uptake of ^H-es tradiol
. Both CI-628 and nafoxi-
dine produce inhibition of sexual receptivity as well as
substantial reduction of brain -^H-es tradiol when injected
2 hours prior to estradiol. CI-628 injected subsequent to
3 3
an H-estradiol injection reduces brain H-estradiol reten-
tion, and others have demonstrated that CI-628 can inhibit
sexual behavior when injected subsequent to estradiol
(Whalen and Gorzalka, 1973) or EB (Blaustein and Vade,
unpublished). MER-25 injected 12 hours prior to estradiol
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inhibits both 2-hour uptake and sexual behavior. MER-25
injected
-2 hours prior to estradiol inhibits neither the
3early uptake of H-estradiol nor estradiol-induced sexual
behavior. Although the 12-hour retention of ^H-estradiol
was inhibited by MER-25, this delayed inhibitory action
was apparently not sufficient to antagonize the higher dose
of estradiol used in the behavioral studies (3 ug cf. .3 ug).
The behavioral actions of the antiestrogens are
probably due to specific interactions with estrogen-sensitive
tissues rather than toxic effects of the drugs. The dose
of MER-25 used in this study fails to produce a learned
aversion (Experiment 5), an objective index of toxicity.
The demonstration that antiestrogens are capable of
competing with estradiol for brain estradiol receptors is
only a first step in determining the mechanism by which they
exert their inhibition of estradiol-induced sexual behavior.
The reasons that this presumed antiestrogen-receptor complex
is less effective than the estradiol-receptor complex
remain to be determined. One hypothesis (Capony, and Roche-
fort, 1975; Clark and Peck, 1976) of the inhibitory action
of antiestrogens in the uterus suggests that antiestrogens
are capable of binding to cytosol receptors and are fully
capable of translocating them to the nucleus in order to
produce an initial estrogenic response. However, the
antiestrogen-receptor complex fails to cause the replenish-
ment of the cytosol receptors which is required for a full
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estrogenic response, or causes only a delayed replenish-
ment. A delay of replenishment has also been suggested as
a mechanism of antagonism for behavioral responses (Whalen,
Martin, and Olsen, 1975). This hypothesis as well as others
(Katzenellenbogen, and Ferguson, 1975; Ruh and Ruh, 19714.)
presupposes competition of the antiestrogen and estrogen
for the estrogen receptors. Beyond this competition,
demonstrated here and elsewhere, there is at present little
evidence to support any particular hypothesis of anti-
estrogens' actions in the central nervous system.
Some experiments which have provided evidence that a
failure of replenishment is a mechanism of antagonism in
the uterus have not produced analogous results when trans-
ferred to behavioral paradigms. For example, when an
(antiestrogen and estrogen are given concurrently, no inhi-
bition of the estrogen's effect on uterine weight is seen
at 21^ hoursj (Clark, Peck, and Anderson, 1971;; Lerner,
Holthaus, and Thompson, 1958) » but in a similar paradigm
asxual behavior can be totally inhibited. Also CI-628 and
nafoxidine by themselves produce an initial estrogenic
response on uterine weight and morphology (Clark, Peck,
and Anderson, 19714-; Kang, Anderson, and DeSombre, 1975)
»
whereas there is no evidence of an estrogenic effect of
these ajities trogens for normal female sexual behavior in
rats (Aral and Gorski, I968; Meyerson and Lindstrom, 1968;
Powers, 1975; Ross, Shryne, Gorski, and Marshall, 1973;
Sodersten, I97I4.). It should be noted that some estrogenic
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central responses to antiestrogens have been reported:
MER-25 and CI-628 have estrogenic central effects on the
regulation of eating behavior (PART I); MER-25 acts as an
estrogen on male copulatory behavior ( Baum and Vreeburg,
1976); CI-628 produces estrogenic responses on certain
hypothalamic enzyme activities (Luine, Wallach, and McEwen,
1975); and cJLs-clomiphene can facilitate or inhibit
sexual behavior in female guinea pigs depending on the
experimental paradigm (Walker and Peder, in preparation).
Therefore, the subcellular actions of antiestrogens that
allox>r them to inhibit estradiol-induced female sexual
behavior are likely to be partially estrogenic actions.
Characterization of the partial actions of the antiestro-
gens may suggest which aspects of natural estrogen action
are important in the induction of sexual behavior, as well
as which aspects are important in the effects of estrogens
on eating. The results presented here are not inconsistent
with a receptor-mediated nuclear action of estradiol to
Induce sexual receptivity, but actual support for this
notion will require assays of receptor dynamics and other
responses with and without antiestrogen involvement,
Antiestrogens may thus be useful in two ways: First,
for sexual behavior and other responses which antiestrogens
inhibit, an analysis of subcellular responses which anti-
estrogens prevent may tentatively link the estrogenic
induction of a behavior to certain" subcellular responses.
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For example, if anties trogens prevented the nuclear locali-
zation of receptors, it would suggest, though not establish,
that nuclear localization of the receptors which antiestro-
gens do elicit might be involved in the behavioral effects
that antiestrogens induce. Thus the antiestrogens are
actually partial estrogens and partial antiestrogens,
depending on the behavior observed, and these estrogenic
and estrogen-antagonizing behavioral effects may be corre-
lated with subcellular responses.
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